Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently contributed to an editorial in Pharmtech.com discussing the importance of collaboration between innovators, manufacturing partners, and the entire supply chain when preparing for rapid scale-up of COVID-19 vaccine candidates.
Read the full article here.
Excerpted from PharmTech.com editorial titled, "Preparing Pandemic Vaccine Capacity"
The biopharmaceutical industry is working at unprecedented speed to develop and manufacture vaccines for the COVID-19 pandemic. Among the challenges of a pandemic is the need to scale up to billions of doses, at a larger scale than typically needed for vaccines, from raw materials all the way through to the materials for the containers for fill/finish.
Vol. 33, No. 9
J. Markarian, "Preparing Pandemic Vaccine Capacity," BioPharm International, 33 (9) 2020.